Polymeric Micelles for the Delivery of Poorly Soluble Drugs

Drug Delivery Strategies for Poorly Water-Soluble Drugs

Volumn , Issue , 2013, Pages 411-476

  Biswas, Swati ^a   Vaze, Onkar S ^a   Movassaghian, Sara ^a,b   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amphiphilic; Copolymer; Critical micelles concentrations; Drug delivery; Hydrophobic; Micelles; Micellization; Multifunctional; Polymeric; Targeting

Indexed keywords

EID: 84887240198     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118444726.ch14     Document Type: Chapter

References (343)

1. V.P. Torchilin, Structure and design of polymeric surfactant-based drug delivery systems, J Control Release, 73, 137-172 (2001).
2. V.P. Torchilin, PEG-based micelles as carriers of contrast agents for different imaging modalities, Adv Drug Deliv Rev, 54, 235-252 (2002).
3. V.P. Torchilin, Lipid-core micelles for targeted drug delivery, Curr Drug Deliv, 2, 319-327 (2005).
4. V.P. Torchilin, Micellar nanocarriers: Pharmaceutical perspectives, Pharm Res, 24, 1-16 (2007).
5. P. Mukerjee, Analysis of distribution model for micellar solubilization using thermodynamics of small systems: Nonideality of solubilization of benzoic acid derivatives in nonionic surfactants, J Pharm Sci, 60, 1531-1534 (1971).
6. W.C. Preston, Some correlating principles of detergent action, J Phys Colloid Chem, 52, 84-97 (1948).
7. P.A. Kralchevsky, K.D. Danov, N.D. Denkov, Handbook of Surface and Colloid Chemistry, 2nd edn. Boca Raton, FL: CRC Press (2003).
8. A. Martin, Physical Pharmacy, 4th edn. Baltimore, MD:Williams andWilkins (1993).
9. C. Tanford, Thermodynamics of micelle formation: Prediction of micelle size and size distribution, Proc Natl Acad Sci U S A, 71, 1811-1815 (1974).
10. B. Lindman, H.Wennerstrom, Micelles. Amphiphile aggregation in aqueous solution, Top Curr Chem, 87, 1-87 (1980).
11. C. Tanford, Ionization of cationic micelles: Effect of the detergent structure, J Phys Chem, 78, 2469-2479 (1974).
12. C. Tanford, Micelle shape and size, J Phys Chem, 76, 3020-3024 (1972).
13. C. Tanford, The Hydrophobic Effect: Formation of Micelles and Biological Membranes, New York: Wiley (1973).
14. C. Tanford, Micellization, Solubilization, and Microemulsions, Vol. 1, K.L. Mittal (ed.). New York: Wiley (1977).
15. D. Myers, Surfactant Science and Technology, 3rd edn. Hoboken, NJ: Wiley-Interscience (2006).
16. A.S. Mikhail, C. Allen, Block copolymer micelles for delivery of cancer therapy: Transport at the whole body, tissue and cellular levels, J Control Release, 138, 214-223 (2009).
17. K. Kataoka, A. Harada, Y. Nagasaki, Block copolymer micelles for drug delivery: design, characterization and biological significance,AdvDrugDelivRev, 47, 113-131 (2001).
18. R.R. Sawant,V.P. Torchilin, Multifunctionality of lipid-core micelles for drug delivery and tumour targeting, Mol Membr Biol, 27, 232-246 (2010).
19. M. Jones, and J. Leroux, Polymeric micelles: A new generation of colloidal drug carriers, Eur J Pharm Biopharm, 48, 101-111 (1999).
20. K. Yokogawa, E. Nakashima, J. Ishizaki, H. Maeda, T. Nagano, F. Ichimura, Relationships in the structure-tissue distribution of basic drugs in the rabbit, Pharm Res, 7, 691-696 (1990).
21. C.A. Lipinski, Drug-like properties and the causes of poor solubility and poor permeability, J Pharmacol Toxicol Methods, 44, 235-249 (2000).
22. C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, 46, 3-26 (2001).
23. V.P. Torchilin, A.N. Lukyanov, Z. Gao, B. Papahadjopoulos-Sternberg, Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs, Proc Natl Acad Sci U S A, 100, 6039-6044 (2003).
24. S.H. Yalkowsky, Techniques of Solubilization of Drugs. New York: Marcel Dekker (1981).
25. H.C. Ansel, L.V. Allen, N.G. Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems, Baltimore, MD: Lippincott, Williams, and Wilkins (1999).
26. P.P. Constantinides, K.J. Lambert, A.K. Tustian, B. Schneider, S. Lalji, W. Ma, B. Wentzel, D. Kessler, D. Worah, S.C. Quay, Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel, Pharm Res, 17, 175-182 (2000).
27. M.J. Rosen (ed.), Surfactants and Interfacial Phenomena, New York: Wiley-Interscience (1989).
28. S.B. La, T. Okano, K. Kataoka, Preparation and characterization of the micelleforming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(betabenzyl L-aspartate) block copolymer micelles, J Pharm Sci, 85, 85-90 (1996).
29. A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery, J Control Release, 82, 189-212 (2002).
30. M. Yokoyama, T. Sugiyama, T. Okano, Y. Sakurai, M. Naito, K. Kataoka, Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography, Pharm Res, 10, 895-899 (1993).
31. V.P. Torchilin, V.S. Trubetskoy, Which polymers can make nanoparticulate drug carriers long circulating?, Adv Drug Deliv Rev, 16, 141-155 (1995).
32. G.S. Kwon, Diblock copolymer nanoparticles for drug delivery, Crit Rev Ther Drug Carrier Syst, 15, 481-512 (1998).
33. G.S. Kwon, K. Kataoka, Block copolymer micelles as long circulating drug vehicles, Adv Drug Deliv Rev, 16, 295-309 (1995).
34. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review, J Control Release, 65, 271-284 (2000).
35. T.N. Palmer, V.J. Caride, M.A. Caldecourt, J. Twickler, V. Abdullah, The mechanism of liposome accumulation in infarction, Biochim Biophys Acta, 797, 363-368 (1984).
36. A.A. Gabizon, Liposome circulation timr and tumor targeting: Implications for cancer therapy, Adv Drug Deliv Rev, 16, 285-294 (1995).
37. G. Gregoriadis, Targeting of drugs, Nature, 265, 407-411 (1977).
38. E. Batrakova, S. Lee, S. Li, A. Venne, V. Alakhov, A. Kabanov, Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells, Pharm Res, 16, 1373-1379 (1999).
39. I. Astafieva, A. Zhong, A. Eisenberg, Critical micellization phenomena in block polyelectrolyte solution, Macromolecules, 26, 7339-7352 (1993).
40. A. Kabanov, V. Alakhov, Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers, Crit Rev Ther Drug, 19, 1-73 (2002).
41. P. Alexandridis, J.F. Holzwarth, T.A. Hatton, Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solution: Thermodynamics of copolymer association, Macromolecules, 27, 2414-2425 (1994).
42. M. Yokoyama, S. Fukushima, R. Uehara, K. Okamoto, K. Kataoka, Y. Sakurai, T. Okano, Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor, J Control Release, 50, 79-92 (1998).
43. A.K. Rakshit, R.M. Palepu, Additive effects on non-ionic surfactant assemblies: A review, Recent Dev Coll Interface Res, 1, 203-219 (2003).
44. R. Nagarajan, Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPO-PEO) block copolymers, Coll Surfaces B Biointerf, 16, 55-72 (1999).
45. H.H. Bader, B. Ringsdorf, B. Schmidt, Water soluble polymers in medicine, Angew Chem, 123/124, 457-463 (1984).
46. V.Y. Alakhov, A.V. Kabanov, Block copolymeric biotransport carriers as versatile vehicles for drug delivery, Expert Opin Investig Drugs, 7, 1453-1473 (1998).
47. R.R. Sawant, V.P. Torchilin, Polymeric micelles: Polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example, Methods Mol Biol, 624, 131-149 (2010).
48. H.G. Schild, D.A.R. Tirrel, Microheterogenous solutions of amphiphilic copolymers of N-isopropylacrylamide: An investigation via fluorescence methods, Langmuir, 7, 1319-1324 (1991).
49. C. Li, S.Wallace, Polymer-drug conjugates: Recent development in clinical oncology, Adv Drug Deliv Rev, 60, 886-898 (2008).
50. C.C. Lee, J.A. MacKay, J.M. Fréchet, F.C. Szoka, Designing dendrimers for biological applications, Nat Biotechnol, 23, 1517-1526 (2005).
51. V.P. Torchilin, Recent advances with liposomes as pharmaceutical carriers, Nat Rev Drug Discov, 4, 145-160 (2005).
52. E.R. Gillies, J.M. Fréchet, Dendrimers and dendritic polymers in drug delivery, Drug Discov Today, 10, 35-43 (2005).
53. A. Gopin, S. Ebner, B. Attali, D. Shabat, Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry, Bioconjug Chem, 17, 1432-1440 (2006).
54. J. Liu, H. Lee, M. Huesca, A. Young, C. Allen, Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy, Cancer Chemother Pharmacol, 58, 306-318 (2006).
55. A. Benahmed, M. Ranger, J.C. Leroux, Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,Llactide), Pharm Res, 18, 323-328 (2001).
56. J.E. Chung, M. Yokoyama, M. Yamato, T. Aoyagi, Y. Sakurai, T. Okano, Thermoresponsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate), J Control Release, 62, 115-127 (1999).
57. W.Y. Chen, C.K. Su, C.S. Patrickios, W.R. Hertler, T.A. Hatton, Effect of block size and sequence on the micellization of ABC triblock methacrylic acid polyampholytes, Macromolecules, 28, 8604-8611 (1995).
58. J.E. Chung, M. Yokoyama, T. Aoyagi, Y. Sakurai, T. Okano, Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers, J Control Release, 53, 119-130 (1998).
59. J.E. Chung, M. Yokoyama, T. Okano, Inner core segment design for drug delivery control of thermo-responsive polymeric micelles, J Control Release, 65, 93-103 (2000).
60. D. Sutton, N. Nasongkla, E. Blanco, J. Gao, Functionalized micellar systems for cancer targeted drug delivery, Pharm Res, 24, 1029-1046 (2007).
61. P. Becher, R.L. Birkmeier, The determination of hydrophile-lipophile balance (HLB) by gas-liquid chromatography (GLC), J Am Oil, Chem Soc, 41, 169-172 (1964).
62. E.V. Batrakova, A.V. Kabanov, Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers, J Control Release, 130, 98-106 (2008).
63. M. Kozlov, N. Melik-Nubarov, E. Batrakova, A. Kabanov, Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes, Macromolecules, 33, 3305-3313 (2000).
64. A.V. Kabanov, V.Y. Alakhov, Pluronic block copolymers in drug delivery: From micellar nanoontainers to biological response modifiers, Crit Rev Ther Drug, 19, 1-73 (2002).
65. T.P. Johnston, .C. Miller, Toxicological evaluation of poloxamer vehicles for intramuscular use, J Parenter Sci Technol, 39, 83-89 (1985).
66. E.V. Batrakova, S. Li, Y. Li, V.Y. Alakhov,W.F. Elmquist, A.V. Kabanov, Distribution kinetics of a micelle-forming block copolymer Pluronic P85, J Control Release, 100, 389-397 (2004).
67. M.W. Edens, Nonionic Surfactants: Polyoxyalkylene Block Copolymers, Vol. 60, ed. Nace V.M., New York (1996).
68. A.V. Kabanov, P. Lemieux, S. Vinogradov, V. Alakhov, Pluronic block copolymers: Novel functional molecules for gene therapy, Adv Drug Deliv Rev, 54, 223-233 (2002).
69. B. Chu, Z. Zhou, Onionic Surfactants: Polyoxy-alkylene Block Copolymers, Vol. 60, New York: Marcel Dekker, Inc. (1996).
70. A. Kabanov, E. Batrakova, N.S. Melik-Nubarov, N.A. Fedoseev, T.Y. Dorodnich, V. Alakhov, V.P. Chekhonin, I.R. Nazarova, V.A. Kabanov, A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain, J Control Release, 22, 141-158 (1992).
71. A.V. Kabanov, V.P. Chekhonin, V. Alakhov, E.V. Batrakova, A.S. Lebedev, N.S. Melik-Nubarov, S.A. Arzhakov, A.V. Levashov, G.V. Morozov, E.S. Severin, et al. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: Micelles as microcontainers for drug targeting, FEBS Lett, 258, 343-345 (1989).
72. S.Y. Lin, Y. Kawashima, Kinetic studies on the stability of indomethacin in alkaline aqueous solution containing poly(oxyethylene)poly(oxypropylene) surface-active block copolymers, Pharm Acta Helv, 60, 345-350 (1985).
73. E.V. Batrakova, T.Y. Dorodnych, E.Y. Klinskii, E.N. Kliushnenkova, O.B. Shemchukova, O.N. Goncharova, S.A. Arjakov, V.Y. Alakhov, A.V. Kabanov, Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity, Br J Cancer, 74, 1545-1552 (1996).
74. D. Forster, C. Washington, S.S. Davis, Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes, J Pharm Pharmacol, 40, 325-328 (1988).
75. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert, M. Ranson, Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer, Br J Cancer, 90, 2085-2091 (2004).
76. R.L. Hunter, B. Bennett, The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces, Scand J Immunol, 23, 287-300 (1986).
77. R.L. Hunter, J. McNicholl, A.A. Lal, Mechanisms of action of nonionic block copolymer adjuvants, AIDS Res Hum Retroviruses, 10 (Suppl 2), S95-S98 (1994).
78. R. Hunter, F. Strickland, F. Kezdy, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance, J Immunol, 127, 1244-1250 (1981).
79. A.V. Kabanov, E.V. Batrakova, S. Sriadibhatla, Z. Yang, D.L. Kelly, V.Y. Alakov, Polymer genomics: Shifting the gene and drug delivery paradigms, J Control Release, 101, 259-271 (2005).
80. A. Kabanov, J. Zhu, V. Alakhov, Pluronic block copolymers for gene delivery, Adv Genet, 53, 231-261 (2005).
81. A.V. Kabanov, Polymer genomics: An insight into pharmacology and toxicology of nanomedicines, Adv Drug Deliv Rev, 58, 1597-1621 (2006).
82. Y. Romsicki, F.J. Sharom, The ATPase and ATP-binding functions of P-glycoprotein-modulation by interaction with defined phospholipids, Eur J Biochem, 256, 170-178 (1998).
83. A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, Pluronic block copolymers for overcoming drug resistance in cancer, Adv Drug Deliv Rev, 54, 759-779 (2002).
84. E.V. Batrakova, S. Li, W.F. Elmquist, D.W. Miller, V.Y. Alakhov, A.V. Kabanov, Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion, Br J Cancer, 85, 1987-1997 (2001).
85. Y. Romsicki, F.J. Sharom, The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter, Biochemistry, 38, 6887-6896 (1999).
86. G.D. Luker, C.M. Pica, A.S. Kumar, D.F. Covey, D. Piwnica-Worms, Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains, Biochemistry, 39, 7651-7661 (2000).
87. E.V. Batrakova, S. Li, V.Y. Alakhov, D.W. Miller, A.V. Kabanov, Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells, J Pharmacol Exp Ther, 304, 845-854 (2003).
88. E.V. Batrakova, D.W. Miller, S. Li, V.Y. Alakhov, A.V. Kabanov, W.F. Elmquist, Pluronic P85 enhances the delivery of digoxin to the brain: In vitro and in vivo studies, J Pharmacol Exp Ther, 296, 551-557 (2001).
89. E.V. Batrakova, S. Li, S.V. Vinogradov, V.Y. Alakhov, D.W. Miller, A.V. Kabanov, Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization, J Pharmacol Exp Ther, 299, 483-493 (2001).
90. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, M.M. Gottesman, Targeting multidrug resistance in cancer, Nat Rev Drug Discov, 5, 219-234 (2006).
91. R. Regev, H. Katzir, D.Yeheskely-Hayon, G.D. Eytan, Modulation of P-glycoproteinmediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane, FEBS J, 274, 6204-6214 (2007).
92. E.V. Batrakova, S. Li, V.Y. Alakhov, W.F. Elmquist, D.W. Miller, A.V. Kabanov, Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85, Pharm Res, 20, 1581-1590 (2003).
93. T. Yamagata, H. Kusuhara, M. Morishita, K. Takayama, H. Benameur, Y. Sugiyama, Effect of excipients on breast cancer resistance protein substrate uptake activity, J Control Release, 124, 1-5 (2007).
94. T. Yamagata, H. Kusuhara, M. Morishita, K. Takayama, H. Benameur, Y. Sugiyama, Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients, Drug Metab Dispos, 35, 1142-1148 (2007).
95. T. Minko, E.V. Batrakova, S. Li, Y. Li, R.I. Pakunlu, V.Y. Alakhov, A.V. Kabanov, Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drugresistant cancer cells, J Control Release, 105, 269-278 (2005).
96. A.Venne, S. Li, R. Mandeville, A. Kabanov, V. Alakhov, Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells, Cancer Res, 56, 3626-3629 (1996).
97. D.W. Miller, E.V. Batrakova, T.O. Waltner, V. Alakhov, A.V. Kabanov, Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption, Bioconjug Chem, 8, 649-657 (1997).
98. W.J. Gibbs, T.M. Hagemann, Purified poloxamer 188 for sickle cell vaso-occlusive crisis, Ann Pharmacother, 38, 320-324 (2004).
99. S.L. Frey, K.Y. Lee, Temperature dependence of poloxamer insertion into and squeeze-out from lipid monolayers, Langmuir, 23, 2631-2637 (2007).
100. G. Wanka, H. Hoffman, W. Ulbricht, Phase diagrams and aggregation behavior of poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous soluions, Macromolecules, 27, 4145-4159 (1994).
101. V. Alakhov, E. Klinski, S. Li, G. Pietrzynski, A.Venne, E. Batrakova, Block copolymer-based formulation of doxorubicin: From cell screen to clinical trials, Colloids Surf A, 16, 113-134 (1999).
102. J. Meadows, S. Higginbottom, Anaesthetic formulation of propofol. U.S. Patent 20040253277. (2003).
103. S.K. Fridkin,W.R. Jarvis, Epidemiology of nosocomial fungal infections, Clin Microbiol Rev, 9, 499-511 (1996).
104. W.E. Dismukes, Introduction to antifungal drugs, Clin Infect Dis, 30, 653-657 (2000).
105. J. Bennett, Editorial response: Choosing amphotericin B formulations -between a rock and a hard place, Clin Infect Dis, 31, 1164-1165 (2000).
106. M.S. Espuelas, P. Legrand, M.A. Campanero, M. Appel, M. Cheron, C. Gamazo, G. Barratt, J.M. Irache, Polymeric carriers for amphotericin B: In vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice, J Antimicrob Chemother, 52, 419-427 (2003).
107. K. Kataoka, A. Ishihara, A. Harada, H. Miyazaki, Effect of secondary structure of poly(L-Lysine) segments on the micellization of poly(ethylene glycol)-poly(LLysine) block copolymer partially substituted with hydrocinnamoyl group at the Nε-position in aqueous milieu, Macromolecules, 31, 6071-6076 (1998).
108. G. Kwon, S. Suwa, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Enhanced tumor accumulation and prolong circulation times of micelle-forming poly(ethyleneoxide-aspartate)block copolymer-adriamycin conjugates, J Control Release, 29, 17-23 (1994).
109. I. Oh, K. Lee, H.Y. Kwon, Y.B. Lee, S.C. Shin, C.S. Cho, C.K. Kim, Release of adriamycin from poly(gamma-benzyl-L-glutamate)/poly(ethylene oxide) nanoparticles, Int J Pharm, 181, 107-115 (1999).
110. E.S. Lee, H.J. Shin, K. Na,Y.H. Bae, Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization, J Control Release, 90, 363-374 (2003).
111. M.L. Adams, G.S. Kwon, The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugates, J Biomater Sci Polym Ed, 13, 991-1006 (2002).
112. M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Improved synthesis of adriamycinconjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin, J Control Release, 32, 269-277 (1994).
113. G.S. Kwon, Polymeric micelles for delivery of poorly water-soluble compounds, Crit Rev Ther Drug Carrier Syst, 20, 357-403 (2003).
114. K. Dorn, G. Hoerpel, H. Ringsdorf (eds), Polymeric Anti-Tumor Agents on a Molecular and Cellular Level, New York: Marcel Dekker (1985).
115. V. Alakhov, et al., Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer, Bioconjug Chem, 7(2), 209-216 (1996).
116. N. Nishiyama, K. Kataoka, Polymeric micelle drug carrier systems: PEG-PAsp(DOX) and second generation of micellar drugs, In Advances in Experimental Medicine and Biology, New York: Plenum, pp. 155-177 (2003).
117. Y. Bae, N. Nishiyama, S. Fukushima, H. Koyama, M. Yasuhiro, K. Kataoka, Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy, Bioconjug Chem, 16, 122-130 (2005).
118. Y. Bae, S. Fukushima, A. Harada, K. Kataoka, Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change, Angew Chem Int Ed Engl, 42, 4640-4643 (2003).
119. Y. Li, G.S. Kwon, Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release, Pharm Res, 17, 607-611 (2000).
120. M. Yokoyama, T. Okano, Y. Sakurai, H. Ekimoto, C. Shibazaki, K. Kataoka, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res, 51, 3229-3236 (1991).
121. G.S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Biodistribution of micelle-forming polymer-drug conjugates, Pharm Res, 10, 970-974 (1993).
122. C. Allen, et al., Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818, Bioconjug Chem, 9(5), 564-572 (1998).
123. K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, G.S. Kwon, Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance, J Control Release, 64, 143-153 (2000).
124. B. Yu, T. Okano, K. Kataoka, S. Sardari, G. Kwon, In vitro dissociation and antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(β-benzyl-L-aspartate) micelles, J Control Release, 56, 285-291 (1998).
125. P. Opanasopit, M. Yokoyama, M.Watanabe, K. Kawano, Y. Maitani, T. Okano, Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting, Pharm Res, 21, 2001-2008 (2004).
126. Y. Jeong, J. Cheon, S. Kim, J. Nath, Y. Lee, Y. Sung, Clonazepam release from core-shell type nanoparticles in vitro, J Control Release, 51, 169-178 (1998).
127. M.L. Adams, G.S. Kwon, Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: Effects of acyl chain length, J Control Release, 87, 23-32 (2003).
128. A. Lavasanifar, J. Samuel, G.S. Kwon, The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide), J Control Release, 79, 165-172 (2002).
129. J. Bolard, P. Legrand, F. Heitz, B. Cybulska, One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium, Biochemistry, 30, 5707-5715 (1991).
130. M.L. Adams, D.R. Andes, G.S.Kwon, AmphotericinBencapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity, Biomacromolecules, 43, 750-757 (2003).
131. T. Nakanishi, S. Fukushima, K. Okamoto, M. Suzuki, Y. Matsumura, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Development of the polymer micelle carrier system for doxorubicin, J Control Release, 74, 295-302 (2001).
132. K.S. Anseth, A.T. Metters, S.J. Bryant, P.J. Martens, J.H. Elisseeff, C.N. Bowman, In situ forming degradable networks and their application in tissue engineering and drug delivery, J Control Release, 78, 199-209 (2002).
133. X.S. Wu, N. Wang, Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation, J Biomater Sci Polym Ed, 12, 21-34 (2001).
134. H. Burt, X. Zhang, P. Toleikin, L. Embree,W. Hunter, Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel, Coll Surfaces B Biointerf, 16, 161-171 (1999).
135. X. Zhang, H.M. Burt, D. Von Hoff, D. Dexter, G. Mangold, D. Degen, A.M. Oktaba, W.L. Hunter, An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel, Cancer Chemother Pharmacol, 40, 81-86 (1997).
136. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, S. Wan Kim, M.H. Seo, In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy, J Control Release, 72, 191-202 (2001).
137. K. Huh, Y. Cho, K. Park, PLGA-PEG block copolymers for drug formulations, Drug Del Tech, 3, 44-49 (2003).
138. H.S. Yoo, T.G. Park, Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer, J Control Release, 70, 63-70 (2001).
139. A.L. Klibanov, K. Maruyama, V.P. Torchilin, L. Huang, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett, 268, 235-237 (1990).
140. V.S. Trubetskoy, V. Torchlin, Use of polyoxyethylene-lipid conjugates as longcirculating carriers for delivery of therapeutic and diagnostic agents, Adv Drug Deliv Rev, 16, 311-320 (1995).
141. V.P. Torchilin, M.I. Shtilman, V.S. Trubetskoy, K. Whiteman, A.M. Milstein, Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo, Biochim Biophys Acta, 1195, 181-184 (1994).
142. V.P. Torchilin, T.S. Levchenko, K.R. Whiteman, A.A. Yaroslavov, A.M. Tsatsakis, A.K. Rizos, E.V. Michailova, M.I. Shtilman, Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification, Biomaterials, 22, 3035-3044 (2001).
143. M. Li, A. Chrastina, T. Levchenki,V.P. Torchilin, Micelles from poly(ethylene glycol)-phosphatidyl ethanolamine conjugates (PEG-PE) as pharmaceutical nanocarriers for poorly soluble drug camptothecin, J Biomed Nanotechnol, 1, 190-195 (2005).
144. Z. Gao, A.N. Lukyanov, A. Singhai, V.P. Torchilin, Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs, Nanoletters, 2, 979-982 (2002).
145. J. Wang, D.A. Mongayt, A.N. Lukyanov, T.S. Levchenko, V.P. Torchilin, Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo[5,4,0]undec-7-ene in poly(ethylene glycol)-diacyllipid micelles, Int J Pharm, 272, 129-135 (2004).
146. V. Weissig, K.R. Whiteman, V.P. Torchilin, Accumulation of protein-loaded longcirculating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice, Pharm Res, 15, 1552-1556 (1998).
147. V. Weissig, C. Lizano, V.P. Torchilin, Micellar delivery system for dequalinium-a lipophilic cationic drug with anticarcinoma activity, J Liposome Res, 8, 391-400 (1998).
148. J. Senior, C. Delgado, D. Fisher, C. Tilcock, G. Gregoriadis, Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles, Biochim Biophys Acta, 1062, 77-82 (1991).
149. G. Blume, G. Cevc, Molecular mechanism of the lipid vesicle longevity in vivo, Biochim Biophys Acta, 1146, 157-168 (1993).
150. V.P. Torchilin,V.G. Omelyanenko, M.I. Papisov, A.A. Bogdanov, Jr.,V.S. Trubetskoy, J.N. Herron, C.A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim Biophys Acta, 1195, 11-20 (1994).
151. F.K. Bedu-Addo, P. Tang, Y. Xu, L. Huang, Interaction of polyethyleneglycolphospholipid conjugates with cholesterol-phosphatidylcholine mixtures: Sterically stabilized liposome formulations, Pharm Res, 13, 718-724 (1996).
152. K. Edwards, M. Johnsson, G. Karlsson, M. Silvander, Effect of polyethyleneglycolphospholipids on aggregate structure in preparations of small unilamellar liposomes, Biophys J, 73, 258-266 (1997).
153. A.A. Gabizon, Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy, Cancer Invest, 19, 424-436 (2001).
154. G.B. Jiang, et al., Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery, Mol Pharm, 3(2), 152-60 (2006).
155. Z. Gao, A.N. Lukyanov, A.R. Chakilam, V.P. Torchilin, PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing, J Drug Target, 11, 87-92 (2003).
156. H. Arimura, Y. Ohya, T. Ouchi, Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer, Biomacromolecules, 6, 720-725 (2005).
157. R.D. Dabholkar, R.M. Sawant, D.A. Mongayt, P.V. Devarajan, V.P. Torchilin, Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoproteinmediated efflux, Int J Pharm, 315, 148-157 (2006).
158. L. Li, Y.B. Tan, Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE, J Colloid Interface Sci, 317, 326-331 (2008).
159. M.K. Lee, L. Choi, M.H. Kim, C.K. Kim, Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles, Int J Pharm, 191, 87-93 (1999).
160. A. Martin, Physical Pharmacy, 4th edn. Baltimore, MD:Williams andWilkins (1993).
161. S. Katayose, K. Kataoka, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer, Bioconjug Chem, 8(5), 702-707 (1997).
162. B. Chu, Laser light scattering. In Basic Principles and Practice, 2nd edn. New York: Academic Press (1991).
163. A. Jada, B. Siffert, G. Reiss, Adsorption at the solid-solution interface and micelle formation in water of a PEO-PS-PEO triblock copolymer, Colloids Surf A, 75, 203-209 (1993).
164. F.M. WinniK, S.T.A. Regismond, Fluorescence methods in the study of the interactions of surfactants with polymers, Colloids Surf A, 118, 1-39 (1996).
165. A. Patist, S.S. Bhagwat, K.W. Penfield, P. Aikens, D.O. Shah, On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants, J Surfactants Deterg, 3, 53-58 (2000).
166. N.J. Turro, C.J. Chung, Photoluminescent probes forwater soluble polymers: Pressure and temperature effect on a polyol surfactant, Macromolecules, 17, 2123-2126 (1984).
167. P.C. Heimenz, R. Rajagopalan, Principles of Colloid and Surface Chemistry, 3rd edn. New York: Marcel Dekker (1997).
168. L. Zhang, A. Eisenberg, Thermodynamic vs kinetic aspects in the formation and morphological transitions of crew-cut aggregates produced by self-assembly of polystyrene-b-poly(acrylic acid) block copolymers in dilute solution, Macromolecules, 32, 2239-2249 (1999).
169. C. Allen, D. Maysinger, and A. Eisenberg, Nano-engineering block copolymer aggregates for drug delivery, Colloids Surf B, 16, 3-27 (1999).
170. G. Reiss, Micellization of block copolymers, Prog Polym Sci, 28, 1107-1170 (2003).
171. M. Goldraich, Y. Talmon, Direct-imaging cryo-transmission electron microscopy in the study of colloids and polymer solution, in Amphiphilic Block Copolymers, Alexandridis, P., and Lindman, B. (eds), pp. 253-280, Amsterdam: Elsevier (2000).
172. E. Allenmann, J. Leroux, R. Gurny, Biodegradable nanoparticles of poly(lactic acid) and poly(lactic-co-glycoliv acid) for parental administration. In Pharmaceutical Dosage Forms: Disperse Systems. New York: Marcel Dekker, pp. 163-193 (1998).
173. S.G. Oh, D.O. Shah, Micellar lifetime: Its relevance to various technological processes, J Dispersion Sci Technol, 15, 297-316 (1994).
174. Y.H. Bae, H. Yin, Stability issues of polymeric micelles, J Control Release, 131, 2-4 (2008).
175. D.O. Shah, J.H. Schulman, Influence of calcium, cholesterol, and unsaturation on lecithin monolayers, J Lipid Res, 8, 215-226 (1967).
176. M. Yokoyama, Block copolymers as drug carriers, Crit Rev Ther Drug Carrier Syst, 9, 213-248 (1992).
177. Z. Gao, A. Eisenberg, A model of micellization for block copolymers in solutions, Macromolecules, 26, 7353-7360 (1993).
178. F.M.Winnik, A.R. Davidson, G.K. Hamer, H. Kitano, Amphiphilic poly(N-isopropylacrylamide) prepared by using a lipophilic radical initiator: Synthesis and solution properties in water, Macromolecules, 25, 1876-1880 (1992).
179. S.R. Croy, G.S. Kwon, Polymeric micelles for drug delivery, Curr Pharm Des, 12, 4669-4684 (2006).
180. E.A.G. Aniansson, S.N. Wall, Kinetics of step-wise micelle association, J of Phys Chem, 78, 1024-1030 (1974).
181. E.A.G. Aniansson, S.N. Wall, Kinetics of step-wise micelle association. Correction and improvement, J Phys Chem, 79, 857-858 (1975).
182. E.A.G. Aniansson, S.N.Wall, M. Almgren, H. Hoffman, I. Kielmann,W. Ulbricht, R. Zana, J. Lang, C. Tondre, Theory of the kinetics of micellar equilibria and quantitative interpretation of chemical relaxation studies of micellar solutions of ionic surfactants, J Phys Chem, 80, 905-922 (1976).
183. D. Attwood, A.T. Florence, In Surfactant Systems. London: Chapman and Hall, Ltd. (1983).
184. R. Leung, D.O. Shah, J Colloid Interface Sci, 113 (1986).
185. A. Patist, V. Chhabra, R. Pagidipati, R. Shah, D.O. Shah, Effect of chain length compatibility on micellar stability in sodium dodecyl sulfate/alkyltrimethylammonium bromide solutions, Langmuir, 13, 432-434 (1997).
186. G.S. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Physical entrapment of adriamycin in AB block copolymer micelles, Pharm Res, 12, 192-195 (1995).
187. G. Gaucher, M.H. Dufresne, V.P. Sant, N. Kang, D. Maysinger, J.C. Leroux, Block copolymer micelles: Preparation, characterization and application in drug delivery, J Control Release, 109, 169-188 (2005).
188. S. Kim, Y. Shi, J.Y. Kim, K. Park, and J.X. Cheng, Overcoming the barriers in micellar drug delivery: Loading efficiency, in vivo stability, and micelle-cell interaction, Expert Opin Drug Deliv, 7, 49-62 (2010).
189. J.H. Hildebrand, A critique of the theory of solubility of non-electrolytes, Chem Rev, 44, 37-45 (1949).
190. F.P. Jones, Principles of Polymer Chemistry, Ithaca, NY: Cornell University Press (1953).
191. R.F.M. Liu, G.S. Kwon, Micellelization and Drug Solubility Enhancement Part 2. Boca Raton, FL: CRS Press (2008).
192. K. Letchford, R. Liggins, H. Burt, Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations, J Pharm Sci, 97, 1179-1190 (2008).
193. T.L.S. Ooya, K.M. Huh, K. Park, Hydrotropic Nanocarriers for Poorly Soluble Drugs. Amsterdam: Springer (2006).
194. R.E. Coffman, D.O. Kildsig, Hydrotropic solubilization-mechanistic studies, Pharm Res, 13, 1460-1463 (1996).
195. J. Lee, S.C. Lee, G. Acharya, C.J. Chang, K. Park, Hydrotropic solubilization of paclitaxel: Analysis of chemical structures for hydrotropic property, Pharm Res, 20, 1022-1030 (2003).
196. K.M. Huh, S.C. Lee, Y.W. Cho, J. Lee, J.H. Jeong, K. Park, Hydrotropic polymer micelle system for delivery of paclitaxel, J Control Release, 101, 59-68 (2005).
197. C. Allen, J. Han, Y. Yu, D. Maysinger, A. Eisenberg, Polycaprolactone-bpoly( ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone, J Control Release, 63, 275-286 (2000).
198. S.Y. Lin,Y. Kawashima, The influence of three poly(oxyethylene)poly(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin, Pharm Acta Helv, 60, 339-344 (1985).
199. S.Y. Lin, Y. Kawashima, Pluronic surfactants affecting diazepam solubility, compatibility, and adsorption from i.v. admixture solutions, J Parenter Sci Technol, 41, 83-87 (1987).
200. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue, Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer, Cancer Res, 50, 1693-1700 (1990).
201. S. Katayose, K. Kataoka, Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer, J Pharm Sci, 87(2), 160-163 (1998).
202. M.Yokoyama, A. Satoh,Y. Sakurai, T. Okano,Y. Matsumura, T. Kakizoe, K. Kataoka, Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size, J Control Release, 55, 219-229 (1998).
203. A.V. Kabanov, I.R. Nazarova, I.V. Astafieva, E.V. Batrakova, V.Y. Alakhov, A.A. Yaroslavov, V.A. Kabanov, Micelle Formation and Solubilization of Fluorescent-Probes in Poly(Oxyethylene-B-Oxypropylene-B-Oxyethylene) Solutions, Macromolecules, 28, 2303-2314 (1995).
204. A.V. Kabanov, S.V. Vinogradov, Y.G. Suzdaltseva, V. Alakhov, Water-soluble block polycations as carriers for oligonucleotide delivery, Bioconjug Chem, 6, 639-643 (1995).
205. K. Kataoka, G.S. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai, Block-copolymer micelles as vehicles for drug delivery, Journal of Controlled Release, 24, 119-132 (1993).
206. G.M.N. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(beta.-benzyl L-aspartate), Langmuir, 9, 945-949 (1993).
207. G.S. Kwon, T. Okano, Polymeric micelles as new drug carriers, Advanced Drug Delivery Reviews, 21, 107-116 (1996).
208. V.P. Torchilin. Polyethylene glycol based micelles as carriers of therapeutic and diagnostic agents, STP Pharma, Sco 6, 79-86 (1996).
209. P. Xu, E.A. Van Kirk, S. Li, W.J. Murdoch, J. Ren, M.D. Hussain, M. Radosz, Y. Shen, Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy, Colloids Surf B Biointerfaces, 48, 50-57 (2006).
210. A.A. Exner, T.M. Krupka, K. Scherrer, J.M. Teets, Enhancement of carboplatin toxicity by Pluronic block copolymers, J Control Release, 106, 188-197 (2005).
211. H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, K. Kataoka, Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles, J Control Release, 101, 223-232 (2005).
212. H.M. Aliabadi, D.R. Brocks, A. Lavasanifar, Polymeric micelles for the solubilization and delivery of cyclosporine A: Pharmacokinetics and biodistribution, Biomaterials, 26, 7251-7259 (2005).
213. H.M. Aliabadi, A. Mahmud, A.D. Sharifabadi, A. Lavasanifar, Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A, J Control Release, 104, 301-311 (2005).
214. S.V. Vinogradov, E.V. Batrakova, S. Li, A.V. Kabanov, Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides, J Drug Target, 12, 517-526 (2004).
215. A. Krishnadas, I. Rubinstein, H. Onyuksel, Sterically stabilized phospholipid mixed micelles: In vitro evaluation as a novel carrier for water-insoluble drugs, Pharm Res, 20, 297-302 (2003).
216. S.V. Balasubramanian, R.M. Straubinger, Taxol-lipid interactions: Taxol-dependent effects on the physical properties of model membranes, Biochemistry, 33, 8941-8947 (1994).
217. B.G. Yu, T. Okano, K. Kataoka, G. Kwon, Polymeric micelles for drug delivery: Solubilization and haemolytic activity of amphotericin B, J Control Release, 53, 131-136 (1998).
218. S.A. Hagan, A.G.A. Coombes, M.C. Garnett, S.E. Dunn, M.C. Davies, L. Illum, S.S. Davis, S.E. Harding, S. Purkiss, P.R. Gellert. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization ofwater dispersible micelleforming systems, Langmuir, 12, 2153-2161 (1996).
219. G. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Block copolymer micelles for drug delivery: Loading and release of doxorubicin, Journal of Controlled Release, 48, 195-201 (1997).
220. Č.K. Karel Ulbrich, Z. Tuzar, J.Kopeček. Solution properties of drug carriers based on poly[N-(2-hydroxypropyl)methacrylamide] containing biodegradable bonds, Makromol Chem, 188, 1261-1272 (1987).
221. V.P. Sant, D. Smith, J.C. Leroux, Novel pH-sensitive supramolecular assemblies for oral delivery of poorlywater soluble drugs: Preparation and characterization, J Control Release, 97, 301-312 (2004).
222. E. Fournier, M.H. Dufresne, D.C. Smith, M. Ranger, J.C. Leroux, A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers, Pharm Res, 21, 962-968 (2004).
223. S.D. Li, L. Huang, Pharmacokinetics and biodistribution of nanoparticles, Mol Pharm, 5, 496-504 (2008).
224. L. Brannon-Peppas, J.O. Blanchette, Nanoparticle and targeted systems for cancer therapy, Adv Drug Deliv Rev, 56, 1649-1659 (2004).
225. P. Opanasopit, M. Nishikawa, M. Hashida, Factors affecting drug and gene delivery: Effects of interaction with blood components, Crit Rev Ther Drug Carrier Syst, 19, 191-233 (2002).
226. S.I. Jeona, J.H.L.J.D. Andradea, P.G. De Gennes, Protein-surface interactions in the presence of polyethylene oxide: I. Simplified theory, Journal of Colloid and Interface Science, 142, 149-158 (1991).
227. Y. Yamamoto, K. Yasugi, A. Harada, Y. Nagasaki, K. Kataoka, Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(D,Llactide) block copolymer micelles in aqueous milieu, J Control Release, 82, 359-371 (2002).
228. Y. Yamamoto, Y. Nagasaki, Y. Kato, Y. Sugiyama, K. Kataoka, Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge, J Control Release, 77, 27-38 (2001).
229. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, V.P. Torchilin, R.K. Jain, Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment, Proc Natl Acad Sci U S A, 95, 4607-4612 (1998).
230. R.K. Jain, Transport of molecules, particles, and cells in solid tumors, Annu Rev Biomed Eng, 1, 241-263 (1999).
231. V.P. Torchilin, A.L. Klibanov, L. Huang, S. O'Donnell, N.D. Nossiff, B.A. Khaw, Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium, FASEB J, 6, 2716-2719 (1992).
232. H. Maeda, T. Sawa, T. Konno, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS, J Control Release, 74, 47-61 (2001).
233. A.N. Lukyanov, Z. Gao, L. Mazzola, V.P. Torchilin, Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice, Pharm Res, 19, 1424-1429 (2002).
234. V.S. Trubetskoy, G.S. Gazelle, G.L. Wolf, V.P. Torchilin, Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: Design of longcirculating particulate contrast medium for X-ray computed tomography, J Drug Target, 4, 381-388 (1997).
235. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, R.K. Jain, Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size, Cancer Res, 55, 3752-3756 (1995).
236. F.Yuan, M. Leunig, S.K. Huang, D.A. Berk, D. Papahadjopoulos, R.K. Jain, Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft, Cancer Res, 54, 3352-3356 (1994).
237. W.L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H.A.Weich,V.P. Torchilin, F. Yuan, R.K. Jain, Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor, Cancer Res, 59, 4129-4135 (1999).
238. M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, K. Kataoka, Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system, J Drug Target, 7, 171-186 (1999).
239. M.J. Parr, D. Masin, P.R. Cullis, M.B. Bally, Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: The lack of beneficial effects by coating liposomes with poly(ethylene glycol), J Pharmacol Exp Ther, 280, 1319-1327 (1997).
240. E.S. Lee, K. Na, Y.H. Bae, Polymeric micelle for tumor pH and folate-mediated targeting, J Control Release, 91, 103-113 (2003).
241. P.R. Dash, M.L. Read, K.D. Fisher, K.A. Howard, M. Wolfert, D. Oupicky, V. Subr, J. Strohalm, K. Ulbrich, L.W. Seymour, Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin, J Biol Chem, 275, 3793-3802 (2000).
242. C.P. Leamon, D. Weigl, R.W. Hendren, Folate copolymer-mediated transfection of cultured cells, Bioconjug Chem, 10, 947-957 (1999).
243. C.P. Leamon, P.S. Low, Folate-mediated targeting: From diagnostics to drug and gene delivery, Drug Discov Today, 6, 44-51 (2001).
244. J.H. Jeong, S.H. Kim, S.W. Kim, T.G. Park, In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles, J Biomater Sci Polym Ed, 16, 1409-1419 (2005).
245. S.D. Weitman, A.G. Weinberg, L.R. Coney, V.R. Zurawski, D.S. Jennings, B.A. Kamen, Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis, Cancer Res, 52, 6708-6711 (1992).
246. J.F. Ross, P.K. Chaudhuri, M. Ratnam, Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: Physiologic and clinical implications, Cancer, 73, 2432-2443 (1994).
247. H.S. Yoo, T.G. Park, Folate receptor targeted biodegradable polymeric doxorubicin micelles, J Control Release, 96, 273-283 (2004).
248. E.S. Lee, K. Na, Y.H. Bae, Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor, J Control Release, 103, 405-418 (2005).
249. S.L. Goodman, G. Holzemann, G.A. Sulyok, H. Kessler, Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins, J Med Chem, 45, 1045-1051 (2002).
250. N. Nasongkla, X. Shuai, H. Ai, B.D. Weinberg, J. Pink, D.A. Boothman, J. Gao, cRGD-functionalized polymer micelles for targeted doxorubicin delivery, Angew Chem Int Ed Engl, 43, 6323-6327 (2004).
251. F. Samaniego, D. Young, C. Grimes, V. Prospero, M. Christofidou-Solomidou, H.M. DeLisser, O. Prakash, A.A. Sahin, S. Wang, Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts, Cell Growth Differ, 13, 387-395 (2002).
252. E. Jule, Y. Nagasaki, K. Kataoka, Lactose-installed poly(ethylene glycol)-poly(d,llactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface: A surface plasmon resonance study, Bioconjug Chem, 14, 177-186 (2003).
253. S. Vinogradov, E. Batrakova, S. Li, A. Kabanov, Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells, Bioconjug Chem, 10, 851-860 (1999).
254. M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, S. Inoue, Stabilization of disulfide linkage in drug-polymer-immunoglobulin conjugate by microenvironmental control, Biochem Biophys Res Commun, 164, 1234-1239 (1989).
255. L.Z. Iakoubov, V.P. Torchilin, A novel class of antitumor antibodies: Nucleosomerestricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice, Oncol Res, 9, 439-446 (1997).
256. B.A. Khaw, J.A. Mattis, G. Melincoff, H.W. Strauss, H.K. Gold, E. Haber, Monoclonal antibody to cardiac myosin: Imaging of experimental myocardial infarction, Hybridoma, 3, 11-23 (1984).
257. J.R. Wands, H.E. Blum, Primary hepatocellular carcinoma, N Engl J Med, 325, 729-731 (1991).
258. G. Ashwell, J. Harford, Carbohydrate-specific receptors of the liver, Annu Rev Biochem, 51, 531-554 (1982).
259. Y.I. Jeong, S.J. Seo, I.K. Park, H.C. Lee, I.C. Kang, T. Akaike, C.S. Cho, Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gammabenzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety, Int J Pharm, 296, 151-161 (2005).
260. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, R. Langer, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo, Proc Natl Acad Sci U S A, 103, 6315-6320 (2006).
261. O.C. Farokhzad, S. Jon, A. Khademhosseini, T.N. Tran, D.A. Lavan, R. Langer, Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells, Cancer Res, 64, 7668-7672 (2004).
262. A.D. Ellington, J.W. Szostak, In vitro selection of RNA molecules that bind specific ligands, Nature, 346, 818-822 (1990).
263. C. Tuerk, L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, 249, 505-510 (1990).
264. G. Helmlinger, F. Yuan, M. Dellian, R.K. Jain, Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation, Nat Med, 3, 177-182 (1997).
265. I.F. Tannock, D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res 49, 4373-4384 (1989).
266. F. Kohori, K. Sakai, T. Aoyagi, M. Yokoyama, Y. Sakurai, T. Okano, Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide), J Control Release, 55, 87-98 (1998).
267. H.Yan, K. Tsujii, Potential application of poly(N-isopropylacrylamide) gel containing polymeric micelles to drug delivery systems, Colloids Surf B Biointerfaces, 46, 142-146 (2005).
268. H.Wei, X.Z. Zhang, Y. Zhou, S.X. Cheng, R.X. Zhuo, Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methyl methacrylate), Biomaterials, 27, 2028-2034 (2006).
269. S.Q. Liu, Y.W. Tong, Y.Y. Yang, Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,Ndimethylacrylamide)-b-poly(D,L-lactide- c o-glycolide) with varying compositions, Biomaterials, 26, 5064-5074 (2005).
270. O. Soga, C.F. van Nostrum, M. Fens, C.J. Rijcken, R.M. Schiffelers, G. Storm, W.E. Hennink, Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery, J Control Release, 103, 341-353 (2005).
271. M.C. Jones, M. Ranger, J.C. Leroux, pH-sensitive unimolecular polymeric micelles: Synthesis of a novel drug carrier, Bioconjug Chem, 14, 774-781 (2003).
272. C.H. Wang, G.H. Hsiue, Polymeric micelles with a pH-responsive structure as intracellular drug carriers, J Control Release, 108, 140-149 (2005).
273. M. Hruby, C. Konak, K. Ulbrich, Polymeric micellar pH-sensitive drug delivery system for doxorubicin, J Control Release, 103, 137-148 (2005).
274. W.S. Shim, S.W. Kim, E.K. Choi, H.J. Park, J.S. Kim, D.S. Lee, Novel pH sensitive block copolymer micelles for solvent free drug loading, Macromol Biosci, 6, 179-186 (2006).
275. G.H. Hsiue, C.H.Wang, C.L. Lo, J.P. Li, J.L. Yang, Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(L-lactide) diblock copolymer for application in drug delivery, Int J Pharm, 317, 69-75 (2006).
276. C. Giacomelli, L. Le Men, R. Borsali, J. Lai-Kee-Him, Brisson, A. S. P. Armes, A.L. Lewis, Phosphorylcholine-based pH-responsive diblock copolymer micelles as drug delivery vehicles: Light scattering, electron microscopy, and fluorescence experiments, Biomacromolecules, 7, 817-828 (2006).
277. A.A. Kale, V.P. Torchilin, Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: The effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates, Bioconjug Chem, 18, 363-370 (2007).
278. R.M. Sawant, J.P. Hurley, S. Salmaso, A. Kale, E. Tolcheva, T.S. Levchenko, V.P. Torchilin, 'SMART' drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers, Bioconjug Chem, 17, 943-949 (2006).
279. E.S. Lee, K. Na, Y.H. Bae, Super pH-sensitive multifunctional polymeric micelle, Nano Lett, 5, 325-329 (2005).
280. D.M. Lynn, M.M. Amiji, R. Langer, pH-responsive polymer microspheres: Rapid release of encapsulated material within the range of intracellular pH. Angew Chem Int Ed Engl, 40, 1707-1710 (2001).
281. A. Potineni, D.M. Lynn, R. Langer, M.M. Amiji, Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery, J Control Release, 86, 223-234 (2003).
282. D. Shenoy, S. Little, R. Langer, M. Amiji, Poly(ethylene oxide)-modified poly(betaamino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations, Mol Pharm, 2, 357-366 (2005).
283. N. Rapoport, W.G. Pitt, H. Sun, J.L. Nelson, Drug delivery in polymeric micelles: From in vitro to in vivo, J Control Release, 91, 85-95 (2003).
284. S. Mitragotri, Healing sound: The use of ultrasound in drug delivery and other therapeutic applications, Nat Rev Drug Discov, 4, 255-260 (2005).
285. S. Miyazaki, C. Yokouchi, M. Takada, External control of drug release: Controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats, J Pharm Pharmacol, 40, 716-717 (1988).
286. A. Marin, H. Sun, G. A. Husseini, W. G. Pitt, D. A. Christensen, N. Y. Rapoport, Drug delivery in pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake, J Control Release, 84, 39-47 (2002).
287. G.A. Husseini, D.A. Christensen, N.Y. Rapoport, W.G. Pitt, Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide, J Control Release, 83, 303-305 (2002).
288. Z.G. Gao, H.D. Fain, N. Rapoport, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound, J Control Release, 102, 203-222 (2005).
289. Y. Katayama, T. Sonoda, M. Maeda, A polymeric micelle responding to the protein kinase A signal, Macromolecules, 34, 8569 (2001).
290. A. Napoli, M. Valentini, N. Tirelli, M. Muller, J.A. Hubbell, Oxidation-responsive polymeric vesicles, Nat Mater, 3, 183-189 (2004).
291. J.Wang, D. Mongayt,V.P. Torchilin, Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids, J Drug Target, 13, 73-80 (2005).
292. S.R. Schwarze, A. Ho, A. Vocero-Akbani, S.F. Dowdy, In vivo protein transduction: Delivery of a biologically active protein into the mouse, Science, 285, 1569-1572 (1999).
293. A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, R.L. Juliano, Conjugates of antisense oligonucleotides with the TAT and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions, Pharm Res, 19, 744-754 (2002).
294. V.P. Torchilin, R. Rammohan, V.Weissig, T.S. Levchenko, TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors, Proc Natl Acad Sci U S A, 98, 8786-8791 (2001).
295. T.S. Levchenko, R. Rammohan, N. Volodina, V.P. Torchilin, TAT peptide-mediated intracellular delivery of liposomes, Methods Enzymol, 372, 339-349 (2003).
296. M.M. Fretz, G.A. Koning, E. Mastrobattista, W. Jiskoot, G. Storm, OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis, Biochim Biophys Acta, 1665, 48-56 (2004).
297. V.A. Sethuraman, Y.H. Bae, TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors, J Control Release, 118, 216-224 (2007).
298. R.R. Sawant, R.M. Sawant, V.P. Torchilin, Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: Improved drug solubilization and enhanced in vitro cytotoxicity, Eur J Pharm Biopharm, 70, 51-57 (2008).
299. K.S. Rao, M.K. Reddy, J.L. Horning, V. Labhasetwar, TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs, Biomaterials, 29, 4429-4438 (2008).
300. M. Lewin, N. Carlesso, C.H. Tung, X.W. Tang, D. Cory, D.T. Scadden, R.Weissleder, TAT peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat Biotechnol, 18, 410-414 (2000).
301. M. Zhao, M.F. Kircher, L. Josephson, R. Weissleder, Differential conjugation of TAT peptide to superparamagnetic nanoparticles and its effect on cellular uptake, Bioconjug Chem, 13, 840-844 (2002).
302. M. Zorko, U. Langel, Cell-penetrating peptides: Mechanism and kinetics of cargo delivery, Adv Drug Deliv Rev, 57, 529-545 (2005).
303. E. Vives, J.P. Richard, C. Rispal, B. Lebleu, TAT peptide internalization: Seeking the mechanism of entry, Curr Protein Pept Sci, 4, 125-132 (2003).
304. J.S.Wadia, R.V. Stan, S.F. Dowdy, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis, Nat Med, 10, 310-315 (2004).
305. R.R. Sawant, R.M. Sawant, A.A. Kale, and V.P. Torchilin, The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells, J Drug Target, 16, 596-600 (2008).
306. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J.S. Guthi, S.F. Chin, A.D. Sherry, D. A. Boothman, J. Gao, Multifunctional polymeric micelles as cancer-targeted, MRIultrasensitive drug delivery systems, Nano Lett, 6, 2427-2430 (2006).
307. T.Y. Kim, et al., Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies, Clin Cancer Res, 10(11), 3708-3716 (2004).
308. I.G. Shin, et al., Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization, J Control Release, 51(1), 1-11 (1998).
309. H. Sun, et al., Shell-sheddable micelles based on dextran-SS-poly(epsiloncaprolactone) diblock copolymer for efficient intracellular release of doxorubicin, Biomacromolecules, 11(4), 848-854 (2010).
310. H. Uchino, et al., Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats, Br J Cancer, 93(6), 678-687 (2005).
311. M. Yokoyama, et al., Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size, J Control Release, 55(2-3), 219-229 (1998).
312. C. Zhan, et al., Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect, J Control Release, 143(1), 136-142 (2010).
313. X. Shuai, et al., Core-cross-linked polymeric micelles as paclitaxel carriers, Bioconjug Chem, 15(3), 441-448 (2004).
314. L. Ould-Ouali, et al., Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: A case study with risperidone, J Control Release, 102(3), 657-668 (2005).
315. J. Liu, F. Zeng, C. Allen, Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent. J Control Release, 103(2), 481-497 (2005).
316. V.I. Slepnev, et al., Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymer (pluronic) as a tool for low-molecular compound delivery into a cell: Phosphorylation of intracellular proteins with micelle incorporated. (1996).
317. A. Harada et al., Novel polyion complex micelles entrapping enzyme molecules in the core: Preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium, Macromolecules, 31, 288-294 (1998).
318. A.V. Kabanov, E.V. Batrakova, V.Y. Alakhov, An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers, J Control Release, 91(1-2), 75-83 (2003).
319. A.K. Sharma, et al., Prevention of MDR development in leukemia cells by micelle forming polymeric surfactant, J Control Release, 131(3), 220-227 (2008).
320. A.V. Kabanov, Micelles of amphiphilic block copolymers as vehicles for drug delivery. In Amphiphilic Block Copolymers: Self-assembly and Applications. P. Alexandridis, B. Lindman (eds), Amsterdam: Elsevier, pp. 1-31 (1997).
321. S.I. Masayuki Yokoyama, K. Kataoka, N. Yui, Y. Sakurai, Preparation of adriamycinconjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer: A new type of polymeric anticancer agent, Makromol Chem Rapid Commun, 8(9), 431-435 (1987).
322. M.Yokoyama, et al., Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin, J Drug Target, 12(6), 373-384 (2004).
323. T. Yamamoto, et al., What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core, J Control Release, 123(1), 11-18 (2007).
324. P. Opanasopit, et al., Influence of serum and albumins from different species on stability of camptothecin-loaded micelles, J Control Release, 104(2), 313-321 (2005).
325. M, Watanbe et al., Preparation of campthothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability, Int J Pharm, 308: 183-189 (2006).
326. K. Kawano, et al., Enhanced antitumor effect of campthothecin loaded in longcirculating polymeric micelles, J Control Release, 112(3), 329-332 (2006).
327. A. Hayama, et al., Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro, J Nanosci Nanotechnol, 8(6), 3085-3090 (2008).
328. H. Koide, et al., Particle size-dependent triggering of accelerated blood clearance phenomenon, Int J Pharm, 362(1-2), 197-200 (2008).
329. E.T. Dams, et al., Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes, J Pharmacol Exp Ther, 292(3), 1071-1079 (2000).
330. P. Laverman, et al., Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection, J Pharmacol Exp Ther, 298(2), 607-612 (2001).
331. T. Ishida, et al., Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes, J Control Release, 115(3), 243-250 (2006).
332. T. Ishida, and H. Kiwada, Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes, Int J Pharm, 354(1-2), 56-62 (2008).
333. N. Nishiyama, et al., Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice, Cancer Res, 63(24), 8977-8983 (2003).
334. T. Hamaguchi, et al., NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel, Br J Cancer, 92(7), 1240-1246 (2005).
335. D. Le Garrec, et al., Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a newpolymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation, J Control Release, 99(1), 83-101 (2004).
336. Y.J. Park, et al., Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging, Biomaterials, 23(3), 873-879 (2002).
337. J. Liu, F. Zeng, C. Allen, In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration, Eur J Pharm Biopharm, 65(3), 309-319 (2007).
338. Z. Hu, et al., Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery, J Biomed Mater Res A, 85(3), 797-807 (2008).
339. K. Kawano, et al., Enhanced antitumor effect of camptothecin loaded in longcirculating polymeric micelles, J Control Release, 112(3), 329-332 (2006).
340. S. Kawakami, et al., Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration, J Pharm Sci, 94(12), 2606-2615 (2005).
341. Y. Bae, N. Nishiyama, K. Kataoka, In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments, Bioconjug Chem, 18(4), 1131-1139 (2007).
342. C.J. Rijcken, et al., Hydrolysable core-crosslinked thermosensitive polymeric micelles: Synthesis, characterisation and in vivo studies, Biomaterials, 28(36), 5581-5593 (2007).
343. H.Y. Tian, et al., Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: Synthesis and micelle characterization, Biomaterials, 26(20), 4209-4217 (2005).